UPXI Overview

Upexi, Inc. is a Solana-focused digital asset treasury company. The Company is a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space. Its brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX gummies deliver energy without the crash or jitters, offering an alternative to traditional caffeinated beverages. It is focused on the cryptocurrency industry and the management of cash assets through a cryptocurrency portfolio, primarily focused on Solana tokens and staking of those tokens. The Company utilizes accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases.

Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Upexi, Inc revenue for the last quarter amounts to 8.05M USD, increased 101.02

Upexi, Inc. EPS for the last quarter amounts to -2.94 USD, increased 137.10

Upexi, Inc (UPXI) has 59 emplpoyees as of April 20 2026.

Today UPXI has the market capitalization of 101.85M USD.